Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0019829 (Hodgkin's disease)
 30,247 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Endobronchial metastases of extrapulmonary malignant tumors are very rare and they appear in 1-2% of all the pulmonary metastases cases. By their endoscopic presentation, they are similar to primary bronchogenic carcinoma. Eleven patients with endobronchial metastases were presented, 8 male and 3 female. The average age was 58.27 years (from 37 to 72 years). Primary renal carcinoma existed in 2 patients. The one was operated 5 years before the metastases appeared in bronchus, and the metastases in bronchial wall contributed to the discovery of primary tumor in the other patient. Endobronchial metastases appeared in 3 patients, 2 years after the surgery of malignant colonic or rectal tumor, and in fourth patient it appeared 5 years after the surgery. One female patient sustained mastectomy and the radiation therapy was performed 11 years before the bronchial metastases occurred and the other female patient had the disease revealed a year ago and the polytherapy was performed. In the female patient with non Hodgkin Lymphoma, the change in bronchus was revealed simultaneously as the primary disease. Endobronchial metastases appeared in 2 patients two years after the surgery of malignant melanoma. The disease diagnosis was set by clinical-radiological examination, by endoscopy and by the comparison of histopathologic finding of primary carcinoma and metastases.
 ...
PMID:[Endobronchial metastases in extrapulmonary malignant tumors]. 926 73

Endobronchial metastases (EBM) from extrapulmonary malignant tumors are rare. The most common extrathoracic malignancies associated with EBM are breast, renal and colorectal carcinomas. In this study, we aimed to evaluate the clinical, radiographic and bronchoscopic aspects of patients with EBM who were diagnosed between 1992 and 2002. Data about patients' clinical conditions, symptoms, radiographic and endoscopic findings, and histopathological examination results were investigated. EBM was defined as bronchoscopically visible lesions histopathologically identical to the primary tumor in patients with extrapulmonary malignancies. We found 15 cases with EBM. Primary tumors included breast (3), colorectal (3), and renal (2) carcinomas; Malignant Melanoma (2); synovial sarcoma (1), ampulla of Vater adenocarcinoma (1), pheochromocytoma (1), hypernephroma (1), and Hodgkin's Disease (1). The most common symptoms were dyspnea (80%), cough (66.6%) and hemoptysis (33.3%). Multiple (40%) or single (13.3%) pulmonary nodules, mediastinal or hilar lymphadenopathy (40%), and effusion (40%) were the most common radiographic findings. The mean interval from initial diagnosis to diagnosis of EBM was 32.8 months (range, 0-96 months) and median survival time was 18 months (range, 4-84). As a conclusion, various extrapulmonary tumors can metastasize to the bronchus. Symptoms and radiographic findings are similar with those in primary lung cancer. Therefore, EBM should be discriminated from primary lung cancer histopathologically. Although mean survival time is usually short, long-term survivors were reported. Consequently, treatment must be planned according to the histology of the primary tumor, evidence of metastasis to other sites and medical status of the patient.
 ...
PMID:Endobronchial metastases from extrathoracic malignancies. 1647 29